Introduction Leprosy and COVID19
In the light of the COVID19 pandemic, Infolep has launched this key topic page to share information resources about leprosy and COVID19 as they become available. We have also included information resources about the inclusion of persons with a disability, gender and mental health aspects of COVID19.
Advice about leprosy and COVID-19 from the WHO Global Leprosy Programme, ILEP, and GPZL.
Includes guidance on diagnosis and clinical management of leprosy patients, public health aspects of leprosy in the COVID-19 pandemic, and services for persons living with disabilities and/or psychosocial consequences of leprosy.
Brazilian Society of Hansen's Disease (SBH) guidelines
Considering the COVID-19 pandemic, the Brazilian Society of Hansen's Disease (SBH) decided to prepare brief guidelines on how to deal with the main issues that may arise during the coming months with leprosy patients. There are three versions:
- Guidelines for doctors of the Brazilian Society of Hansen's disease (SBH) on the possibility of coinfection Leprosy and COVID-19
- Orientações aos médicos da Sociedade Bras Brasileira de Hansenologia (SBH) sobre a possibilidade de coinfecção Hanseníase e- COVID-19
- Pautas para las personas afectadas con la enfermedad de Hansen (la lepra) durante la pandemia de COVID-19
WHO issues interim guidance for implementation of NTD programmes
The WHO issues interim guidance for the implementation of NTD programmes. The WHO is in the process of producing more detailed guidance, which will be shared in due course.
We are constantly updating this portal, so please feel free to send in your resources for inclusion.
If you have any updates on how COVID 19 is affecting persons affected by leprosy or want to share any good practices or lessons learned, please send your resources directly to Infolep.